Neurologist, Massachusetts General Hospital
Neurology
Dr. Seth P. Finklestein, MD
|
|
Give Review
Seth P. Finklestein, MD practices Neurology. He went to Harvard Medical School. Harvard Medical School is a top medical university. Harvard Medical School is ranked 1/12 in Research/PrimaryCare. Seth P. Finklestein, MD is also published. He has 99 publications published. The lastest publication: "Activation of distinct motor cortex regions during ipsilateral and contralateral finger movements.' Seth Finklestein accepts Medicare.
Publications
- An optimized dosing regimen of cimaglermin (neuregulin 1β3, glial growth factor 2) enhances molecular markers of neuroplasticity and functional recovery after permanen...
- Recovery of fine motor performance after Ischemic damage to motor cortex is facilitated by cell therapy in the rhesus monkey.
- Dalfampridine improves sensorimotor function in rats with chronic deficits after middle Cerebral artery occlusion.
- Recovery from ischemia in the middle-aged Brain: a nonhuman primate model.
- Phosphodiesterase 5A inhibitors improve functional recovery after Stroke in rats: optimized dosing regimen with implications for mechanism.
- Missing steps in the STAIR case: a Translational Medicine perspective on the development of NXY-059 for treatment of acute ischemic Stroke.
- The case for modality-specific outcome measures in clinical trials of Stroke recovery-promoting agents.
- Human umbilical cord blood cells differentiate into muscle in sjl muscular dystrophy mice.
- Effect of basic fibroblast growth factor treatment on Brain progenitor cells after permanent focal ischemia in rats.
- Growth factors and stem cells as treatments for Stroke recovery.
- Correlation between Brain reorganization, ischemic damage, and neurologic status after transient focal cerebral ischemia in rats: a functional magnetic resonance imagi...
- Motor recovery and cortical reorganization after constraint-induced movement therapy in Stroke patients: a preliminary study.
- Motor cortex activation is related to force of squeezing.
- Stroke: working toward a prioritized world agenda.
- Estimation of the local statistical noise in emission computed tomography.
- Brachytherapy: a minimally invasive option for treating prostate cancer.
- Basic fibroblast growth factor protects against excitotoxicity and chemical hypoxia in both neonatal and adult rats.
- Delayed Stroke following carotid occlusion.
- Imaging of acute arterial injury with 111In-labeled platelets: a comparison with scanning electron micrographs.
- Positron Brain imaging--normal patterns and asymmetries.
- Positron imaging of the normal Brain--regional patterns of cerebral blood flow and metabolism.
- Mood, vegetative disturbance, and dexamethasone suppression test after Stroke.
- The predictive power of diagnostic tests and the effect of prevalence of illness.
- Delayed psychosis after right temporoparietal stroke or trauma: relation to Epilepsy.
- Positron imaging in ischemic stroke Disease.
- Effects of N-substituted phenyltetrahydropyridines on Cerebral high-affinity synaptosomal uptake of dopamine and other monoamines in several mammalian species.
- Neonatal tail posture and its relationship to striatal dopamine asymmetry in the rat.
- Neurochemical asymmetries in the albino rat''s cortex, striatum, and nucleus accumbens.
- Changes in cortical and subcortical levels of monoamines and their metabolites following unilateral ventrolateral cortical lesions in the rat.
- Postinfantile giant cell hepatitis complicating ulcerative colitis: a case report and review of the literature.
- Blood Pressure and arterial compliance in young adults: the Minnesota Children's Blood Pressure Study.
- The neuronal growth-associated protein GAP-43 (B-50, F1): neuronal specificity, developmental regulation and regional distribution of the human and rat mRNAs.
- Late changes in Cerebral monoamine metabolism following focal ventrolateral cerebrocortical lesions in rats.
- Neurological Syndromes after cardiac arrest.
- Radionuclide angiography: a sensitive diagnostic test for anterior circulation ischemia.
- The diagnosis of coma: its pitfalls and limitations.
- Covariant defects in visuospatial abilities and recall of verbal narrative after right hemisphere Stroke.
- Pharmacological approaches to Stroke recovery.
- Intracisternal antisense oligonucleotide to growth associated protein-43 blocks the recovery-promoting effects of basic fibroblast growth factor after focal Stroke.
- Basic fibroblast growth factor enhances axonal sprouting after cortical injury in rats.
- Potential usefulness of basic fibroblast growth factor as a treatment for Stroke.
- Activation of distinct motor cortex regions during ipsilateral and contralateral finger movements.
- Estradiol protects against Ischemic injury.
- Intracisternal osteogenic protein-1 enhances functional recovery following focal Stroke.
- Quantitative assessment of mirror movements after Stroke.
- A functional MRI study of subjects recovered from hemiparetic Stroke.
- Computerized measurement of motor performance after Stroke.
- Postischemic infusion of Cu/Zn superoxide dismutase or SOD:Tet451 reduces Cerebral infarction following focal ischemia/reperfusion in rats.
- Intracisternal basic fibroblast growth factor enhances functional recovery and up-regulates the expression of a molecular marker of neuronal sprouting following focal ...
- Time window of infarct reduction by intravenous basic fibroblast growth factor in focal Cerebral ischemia.
- Delayed administration of basic fibroblast growth factor (bFGF) attenuates cognitive dysfunction following parasagittal fluid percussion Brain injury in the rat.
- bFGF ameliorates focal Ischemic injury by blood flow-independent mechanisms in eNOS mutant mice.
- Intravenous basic fibroblast growth factor decreases Brain injury resulting from focal ischemia in cats.
- Intracisternal basic fibroblast growth factor (bFGF) enhances behavioral recovery following focal Cerebral infarction in the rat.
- The role of polypeptide growth factors in recovery from Stroke.
- Delayed intravenous administration of basic fibroblast growth factor (bFGF) reduces infarct volume in a model of focal Cerebral ischemia/reperfusion in the rat.
- Myocyte-specific enhancer binding factor 2C expression in gerbil Brain following global cerebral ischemia.
- Posttreatment with intravenous basic fibroblast growth factor reduces histopathological damage following fluid-percussion Brain injury in rats.
- Increased expression of basic fibroblast growth factor (bFGF) following focal Cerebral infarction in the rat.
- The potential use of neurotrophic growth factors in the treatment of Cerebral ischemia.
- Hyperacute Stroke: evaluation with combined multisection diffusion-weighted and hemodynamically weighted echo-planar MR imaging.
- Petechial Hemorrhages accompanying lobar Hemorrhage: detection by gradient-echo MRI.
- Delayed administration of basic fibroblast growth factor protects against N-methyl-D-aspartate neurotoxicity in neonatal rats.
- Basic fibroblast growth factor protects against hypoxia-ischemia and NMDA neurotoxicity in neonatal rats.
- The clinical spectrum of Cerebral amyloid angiopathy: presentations without lobar hemorrhage.
- Polyubiquitin gene expression following Cerebral ischemia.
- Basic fibroblast growth factor dilates rat pial arterioles.
- Pretreatment with intraventricular basic fibroblast growth factor decreases infarct size following focal Cerebral ischemia in rats.
- Antidepressant drug treatment for postStroke depression: retrospective study.
- Fibroblast growth factor (FGF) levels in the developing rat Brain.
- Growth factor expression after Stroke.
- Temporal, differential and regional expression of mRNA for basic fibroblast growth factor in the developing and adult rat Brain.
- Basic fibroblast growth factor protects striatal neurons in vitro from NMDA-receptor mediated excitotoxicity.
- Conditioned media from the injured lower vertebrate CNS promote neurite outgrowth from mammalian Brain neurons in vitro.
- Molecular properties of the growth-associated protein GAP-43 (B-50).
- Synthetic analgesics and other phenylpiperidines: effects on uptake and storage of dopamine and other monoamines mouse foreBrain tissue.
- Antioxidants fail to inhibit depletion of striatal dopamine by MPTP.
- Increased activity and phase delay in circadian motility rhythms in geriatric depression. Preliminary observations.
- Comparison of MRI and CT scans in a group of psychiatric patients.
- A factor from the injured lower vertebrate CNS promotes outgrowth from human fetal Brain neurons.
- Anatomical distribution of the growth-associated protein GAP-43/B-50 in the adult rat Brain.
- Increased basic fibroblast growth factor (bFGF) immunoreactivity at the site of focal Brain wounds.
- Synthesis of a growth-associated protein by embryonic rat cerebrocortical neurons in vitro.
- Partial purification and characterization of a neurite-promoting factor from the injured goldfish optic nerve.
- Protein fatty acid acylation in developing cortical neurons.
- Localization of the growth-associated phosphoprotein GAP-43 (B-50, F1) in the human Cerebral cortex.
- Selective depletion of Cerebral norepinephrine with 6-hydroxydopamine and GBR-12909 in neonatal rat.
- Intravenous basic fibroblast growth factor (bFGF) decreases DNA fragmentation and prevents downregulation of Bcl-2 expression in the ischemic Brain following middle ce...
- Intravenous basic fibroblast growth factor produces a persistent reduction in infarct volume following permanent focal ischemia in rats.
- A pilot study of somatotopic mapping after cortical infarct.
- Time window of intracisternal osteogenic protein-1 in enhancing functional recovery after Stroke.
- Basic fibroblast growth factor does not prolong survival in a transgenic model of familial amyotrophic lateral sclerosis.
- Altered locomotor activity in neuropsychiatric patients.
- Assay of plasma thioridazine and metabolites by high-performance liquid chromatography with amperometric detection.
- Neuroprotection and Stroke rehabilitation: modulation and enhancement of recovery.
- Dimeric fibroblast growth factor-2 enhances functional recovery after focal Cerebral ischemia.
- Growth factor treatment of Stroke.
- Functional magnetic resonance imaging of reorganization in rat Brain after stroke.
Schools
Harvard Medical School
Mass Gen Hospital
Moffitt Hospital University Of Ca
UCLA Med Center
Procedures Preformed
- EEG (Electroencephalogram)
- EMG (Electromyography)
Conditions Treated
- Ataxia
- Brain Aneurysm
- Cerebral Artery Thrombosis
- Cerebral Hemorrhage
- View All
Doctors Specialties
- Neurology
Accepted Insurances
Education
-
Massachusetts General Hospital -
UCSF -
UCLA Medical Center -
Harvard Medical School
Hospital
-
Massachusetts General Hospital
Drug Facts
| NPI NUMBER | 1255313359 | |
| NPPES Provider LastName | FINKLESTEIN | |
| NPPES Provider FirstName | SETH | |
| NPPES Provider ZIPCode | 021143117 | |
| NPPES Provider State | MA | |
| Specialty Description | Neurology | |
| Total Claim Count | 140.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1255313359 |
| Last Name Of The Provider | FINKLESTEIN |
| First Name Of The Provider | SETH |
| View All |
Similar Doctors
|
|
Dr. Jeremiah M. Scharf, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Peter N. Kinirons, MB BCH
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Derek P. Narendra, MD |
|
|
Dr. Rene A. Colorado, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. April R. Levin, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Elaine T. Kiriakopoulos, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Gregory J. Allam, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. James D. Berry, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Douglas I. Katz, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Ziad M. Alhumayyd, MD |
|
|
Dr. Sana Syed, MD
This Doctor is OpenDoctor Recommended.
|